ENB Therapeutics is developing therapies to break drug resistance that occurs in over 50% of cancer patients. Our lead product, ENB-001, is a first-in-class, selective small molecule endothelin B receptor (ETBR) inhibitor shown in multiple preclinical studies to significantly reduce tumor growth and prolong survival in cancer animal models. ENB-001 is the key to unlock the full therapeutic potential of immunotherapy by restoring the ability of T-cells to infiltrate tumors, inhibiting metastasis and prolonging patient survival. Granted Orphan Drug Designation by FDA in 2016, ENB-001 has solid market exclusivity and strong IP. A low cost, time efficient development program provides near-term POC within 18 months from financing. A companion diagnostic will detect ETBR pathway over-expressers creating additional opportunities for indication expansion into multiple tumor types and broader participation in the multi-billion-dollar immunotherapy market.
Company Details
- Employees
- 6
- Founded
- -
- Address
- 166 Fifth Ave,
- Phone
- (212) 792-2317
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- enbpharma.com
- HQ
- New York, NY
Enb Therapeutics Questions
Enb Therapeutics's helpline number is (212) 792-2317
Enb Therapeutics's website is enbpharma.com
Enb Therapeutics's LinkedIn profile is https://www.linkedin.com/company/enb-therapeutics
Enb Therapeutics has
6 employees.
View email and phone details for 6
employees at Enb Therapeutics.
Enb Therapeutics's industry is
Pharmaceutical Manufacturing
Enb Therapeutics's top competitors are
Immunic Therapeutics,
Renbio,
Inso Biosciences,
Applied Therapeutics, Inc.,
Celmatix Therapeutics,
Protara Therapeutics,
Aquavit Pharmaceuticals, Inc,
Concarlo Therapeutics,
Ovid Therapeutics,
Tourmaline Bio.
Enb Therapeutics's support email address is info@enbpharma.com
Enb Therapeutics's categories are Pharmaceutical Manufacturing
Enb Therapeutics's founding year is 2015
